Monitor whether the reverse split raises the bid price above $1.00 and sustains it for at least 10 consecutive trading days before the September 14 deadline. Continued non-compliance could lead to delisting, crushing liquidity for this $14M market cap stock.
Price Chart
Executive Summary
CalciMedica resolved its Nasdaq MVLS deficiency by qualifying under the alternative stockholders' equity standard (reported $5.5M equity), but still faces delisting risk from a $1.00 bid price non-compliance, with a deadline of September 14, 2026. The company executed a 1-for-5 reverse stock split on August 28, 2026, in an attempt to cure the bid price issue.
Key Facts
- Nasdaq MVLS deficiency (Rule 5550(b)(2)) closed after staff accepted alternative equity requirement compliance based on $5.5M stockholders' equity as of June 30, 2026.
- Minimum bid price deficiency (Rule 5550(a)(2)) remains unresolved; deadline is September 14, 2026.
- One-for-five reverse stock split implemented on August 28, 2026, to address bid price non-compliance.
Financial Impact
Direct financial exposure: null (no monetary damages). The non-compliance risk threatens Nasdaq listing, which would impair liquidity and potentially trigger debt covenant violations.
Risk Factors
- Failure to regain bid price compliance by September 14, 2026, may lead to Nasdaq delisting.
- Reverse stock split may not sustainably lift the share price above $1.00.
- If delisted, trading would move to OTC markets with severely reduced liquidity and institutional eligibility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-379419 |
| Document: 0001193125-26-379419-index-headers.html | 0001193125-26-379419 |
| Document: 0001193125-26-379419-index.html | 0001193125-26-379419 |
| Document: 0001193125-26-379419.txt | 0001193125-26-379419 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 8-K | $1.02 | awaiting T+20 | — | $1.30 (−27.45%) |
Sep 30, 2026 26d ago | 8-K | $1.65 | awaiting T+20 | — | $1.30 (+21.21%) |
Sep 30, 2026 26d ago | 424B5 | $1.65 | awaiting T+20 | — | $1.30 (+21.21%) |
Sep 2, 2026 7w ago | 8-K | $2.10 $1.65 | ▲ +21.43% | ▲ +21.28% | $1.30 (+38.10%) |
Aug 11, 2026 10w ago | 8-K | $0.6577 $0.4590 | ▲ +30.21% | ▲ +29.15% | $1.30 (−97.66%) |
Aug 11, 2026 10w ago | Press Release | $0.6577 $0.4590 | ▼ −30.21% | ▼ −29.15% | $1.30 (+97.66%) |
Jul 10, 2026 15w ago | 3 | $0.8178 $0.6590 | ▼ −19.42% | ▼ −22.60% | $1.30 (+58.96%) |
Jun 24, 2026 17w ago | 8-K | $0.5973 $0.7159 | ▼ −19.86% | ▼ −19.18% | $1.30 (−117.65%) |
May 12, 2026 23w ago | 8-K | $0.6300 $0.9320 | ▲ +47.94% | ▲ +49.66% | $1.30 (+106.35%) |
Mar 12, 2026 32w ago | EFFECT | $0.7260 $0.6180 | ▼ −14.88% | ▼ −16.85% | $1.30 (+79.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers